Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Medco Balance Sheet Gives PBM Flexibility Ahead Of Medicare Rx

This article was originally published in The Pink Sheet Daily

Executive Summary

The pharmacy benefit manager ended 2003 with $638.5 mil. in cash, which could be used to offer a Medicare Rx plan or to make an acquisition. Medco may create a long-term plan for the cash next year.

You may also be interested in...

Medco Bulks Up On Specialty Pharmacy With Accredo Health Agreement

The PBM enters into a 10-year agreement with retail specialty pharmacy Accredo. The alliance will supplement Medco's Columbus, Ohio specialty pharmacy facility, which manages drug spend of approximately $1.8 bil. a year.

Barr’s Expanded Thalidomide ANDA Could Increase Likelihood Of A Marketed Generic

Amended application includes 50 mg and 100 mg dosage forms, which are used in multiple myeloma.

User Fee Deal For Ad Review Funds Stems From PhRMA DTC Principles

A draft agreement between industry and FDA that would assess user fees for "advisory review" of broadcast direct-to-consumer ads prior to initial public dissemination had its genesis in the Pharmaceutical Research & Manufacturers of America's DTC guiding principles





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts